Latest News

Latest news from the IPHA and the international research-based pharmaceutical industry in Ireland and globally. You may subscribe to the Latest News RSS Feed here.

 

IPHA welcomes new Health Innovation Hub jobs initiative (12/17/2013)
The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed the announcement by Sláinte Healthcare that it will create 80 new jobs in the coming year, as part of the Health Innovation Hub of which IPHA is an industry partner.

Pharmaceutical companies can help efficiency through use of electronic signatures (12/17/2013)
Pharmaceutical companies can benefit from the decsion by the European Medicines Agency's (EMA) to accept digital signatures on documents that require a legally binding signature. Since September, the EMA has been using the procedure on documents related to scientific advice for human medicines, orphan medicines and paediatric-medicine procedures.

Benefits of partnership emphasised at IPHA Annual Meeting (11/26/2013)
The importance of partnership in healthcare and of exploring new opportunities of working together, was the theme of the 20th Irish Pharmaceutical Healthcare Association (IPHA) Annual meeting held at the RDS Concert Hall today 26th November.

IPHA welcomes OECD findings on improved health outcomes (11/22/2013)
The Irish Pharmaceutical Healthcare Association (IPHA), has welcomed a report by the OECD which shows that life expectancy in Ireland has increased by four years in the period 2000 to 2011, despite the fact that we are at the top of the league in terms of both tobacco and alcohol consumption. The use of innovative medicines contributed significantly to these positive developments.

2013 IPHA Annual Meeting Programme (11/11/2013)
The 2013 IPHA Annual Meeting will take place at the RDS Concert Hall on Tuesday 26th November under the theme "Building New Partnerships in Healthcare". See programme below.

Makers of branded medicines are delivering significant savings to the State (11/07/2013)
Pharmaceutical companies that make and supply original branded medicines in Ireland have delivered savings of almost €70 million in the first half of 2013, according to the Irish Pharmaceutical Healthcare Association (IPHA).

Branded pharmaceutical companies deliver savings of €68.5 million in the first 6 months of 2013 to the State medicines bill with more reductions from today (11/01/2013)
The price of many well known branded medicines that no longer have patent protection are set to reduce further from today as a result of the 2012 supply agreement between the Irish Pharmaceutical Healthcare Association (IPHA) and the State.

IPHA comments on IPU survey on medicine shortages (07/19/2013)
Commenting on a survey released today by the IPU on the shortage of some key medicines, the Irish Pharmaceutical Healthcare Association (IPHA), which represents companies producing branded medicines in Ireland, stated that it is committed to ensuring that patients have access to the full range of modern medicines in a timely manner.

Pharmaceutical Companies to Disclose all Financial Relations with Healthcare Professionals (07/03/2013)
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the release of its disclosure code of transfers of value to healthcare professionals and organisations. The code requires all members of EFPIA to disclose transfers of value to HCP’s and HCO’s as of 2016 regarding all transfers in 2015.

New study shows prices of IPHA medicines in Ireland at European average (06/19/2013)
A new study conducted by IMS Healthcare, an independent, international market research firm, on behalf of the Irish Pharmaceutical Healthcare Association (IPHA) has revealed that the prices of IPHA’s members’ medicines in Ireland are now at the average of a basket of nine European countries. IPHA represents the research-based pharmaceutical industry in Ireland who manufacture original, branded medicines.

 

Related Content

Petri dishes
IPHA Press Releases 

IPHA is a member of -

IFPMAAESGPEFPIA

For medicines and clinical trials information visit -

medicines.ieself-care.ieIFPMA Portal